Journal article icon

Journal article

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England

Abstract:

Background Vaccines and prophylactic antibodies against respiratory syncytial virus (RSV) are in development and likely to be available in the next 5–10 years. The most efficient way to use these products when they become available is an important consideration for public health decision makers.

Methods We performed a multivariate regression analysis to estimate the burden of RSV in children younger than 5 years in England (UK), a representative high-income temperate ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Oxford college:
St Cross College
Role:
Author
More from this funder
Name:
National Institute for Health Research
Publisher:
Lancet
Journal:
Lancet. Public health More from this journal
Volume:
2
Issue:
8
Pages:
e367-e374
Publication date:
2017-07-31
Acceptance date:
2017-05-23
DOI:
ISSN:
2468-2667
Pmid:
28804787
Language:
English
Keywords:
Pubs id:
pubs:713684
UUID:
uuid:cc8b116d-e52f-4237-8617-c82e365193b4
Local pid:
pubs:713684
Source identifiers:
713684
Deposit date:
2017-08-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP